Profile

Cover photo
American Cancer Society Family of Journals
41 followers|33,185 views
AboutPostsPhotosVideos

Stream

 
Major events and discoveries in cancer research, prevention, diagnosis, and treatment that took place between 1970 and 1995 are reviewed in the 7th and final installment of this popular series. Go to http://onlinelibrary.wiley.com/enhanced/doi/10.1002/cncr.29365/ to read "A note from history: Landmarks in history of cancer, part 7" by Hajdu, Vadmal, and Tang.
1
Add a comment...
 
Co-testing compared to HPV-only testing was more sensitive for detection of ≥ CIN3 in women aged 30–65. These data suggest that approximately 19% of women with cervical cancer could be misdiagnosed by an HPV-only cervical screen. Go to http://onlinelibrary.wiley.com/enhanced/doi/10.1002/cncy.21544/ to read "Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices" by Blatt et al.
1
Add a comment...
 
Women in a randomized controlled trial who received cognitive-behavioral stress management (CBSM) post-surgery for early stage breast cancer were evaluated at an 8-15 year follow-up (11-year median). Women in the CBSM group reported fewer depressive symptoms and better quality of life than the control group up to 15 years later. Go to http://doi.wiley.com/10.1002/cncr.29076 to read "Long term psychological benefits of cognitive-behavioral stress management for women with breast cancer: 11-year follow-up of a randomized controlled trial" by Stagl et al.
1
Add a comment...
 
Colorectal cancer is the 3rd leading cause of cancer death in men and women in the US. The ACS is committed to fighting this deadly disease, and early detection is one of the first steps in doing so. The new 80% by 2018 initiative sets the goal of 80% adherence to colorectal screening by 2018. To examine the potential results of this endeavor, Cancer has published an article entitled “Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018” http://onlinelibrary.wiley.com/doi/10.1002/cncr.29336/full published March 12, 2015. It is accompanied by an editorial authored by our Editor-in-Chief, Dr. Fadlo R. Khuri, and our epidemiology Section Editor, Dr. Electra D. Paskett, entitled “Can we achieve an 80% screening rate for colorectal cancer by 2018 in the United States?” http://onlinelibrary.wiley.com/doi/10.1002/cncr.29335/full.

The American Cancer Society Family of Journals has additional content to help inform our readers on the ongoing fight against colorectal cancer, including:

“Cancer screening in the United States, 2015: A review of current American Cancer Society guidelines and current issues in cancer screening” http://onlinelibrary.wiley.com/doi/10.3322/caac.21261/full published January 8, 2015 in CA: A Cancer Journal for Clinicians.

“Colorectal cancer statistics, 2014” http://onlinelibrary.wiley.com/doi/10.3322/caac.21220/full published March 17, 2014 in CA: A Cancer Journal for Clinicians.
1
Add a comment...
 
The outcome for children with cancer has improved significantly over the past 60 years, with greater than 80% of patients today becoming 5-year survivors. Despite this progress, cancer remains the leading cause of death from disease in children in the United States, and significant short-term and long-term treatment toxicities continue to impact the majority of children with cancer. Go to http://onlinelibrary.wiley.com/enhanced/doi/10.3322/caac.21273/ to read "Improving the outcome for children with cancer: Development of targeted new agents" by Peter C. Adamson, MD.
Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in About Cookies.
1
Add a comment...
 
In addition to establishing the diagnosis of cancer, tumor biopsies are being increasingly used for determining the presence of molecular targets, confirming pharmacodynamic effects and tumor banking, yet the risks and accuracy of these procedures in pediatric patients are unknown. In a review of an extensive experience, authors found that tumor biopsies in children are associated with an acceptably low incidence of clinically relevant adverse events (<8%) and have a high (>90%) diagnostic accuracy. Go to http://onlinelibrary.wiley.com/doi/10.1002/cncr.29167/full to read "Safety and diagnostic accuracy of tumor biopsies in children with cancer" by Interiano et al.
1
Add a comment...
Have them in circles
41 people
Chris S. Paul's profile photo
Antonio Shaw's profile photo
Antonio Shaw's profile photo
Carissa Gilman's profile photo
prIME Oncology's profile photo
Hejamady S's profile photo
Maryam Yassi's profile photo
Sheng Jiang's profile photo
BioSequence's profile photo
 
A new study indicates that vaccinating 12-year-old boys against HPV may be a cost-effective strategy for preventing oropharyngeal squamous cell cancer. The study provides important information about HPV vaccination, which has proven effective against HPV-related disease in both sexes but remains controversial, especially in males. Go to http://onlinelibrary.wiley.com/enhanced/doi/10.1002/cncr.29111/ to read "A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer" by Graham et al.
1
Add a comment...
 
In this editorial, the Editor-in-Chief and Section Editor for Chest and Lung Disease explain why Cancer will no longer consider any work that is funded directly or indirectly from tobacco companies or their subsidiaries. Go to http://onlinelibrary.wiley.com/enhanced/doi/10.1002/cncr.29361/ to read "Time to divest from tobacco-funded research" by Fadlo R. Khuri MD and Suresh S. Ramalingam MD.
1
Add a comment...
 
We would like to congratulate Dr. Fadlo R. Khuri, Editor-in-Chief of Cancer, on his new appointment as the 16th president of the American University of Beirut. http://www.aub.edu.lb/news/2015/Pages/fadlo-khuri-new-president.aspx
The American University of Beirut, AUB, is a private, non-sectarian institution of higher learning, founded in 1866, which functions under a charter from the State of New York. It is administrated by a private, autonomous Board of Trustees.
1
Add a comment...
 
A family history of prostate cancer among first degree relatives increases one's risk for breast cancer diagnosed after age 50. Information on family cancer history is critical for risk assessment and may influence decisions about screening for early detection. Go to http://onlinelibrary.wiley.com/doi/10.1002/cncr.29075/full to read "Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study" by Beebe-Dimmer et al.
1
Add a comment...
 
The distinction between renal oncocytoma and chromophobe renal cell carcinoma can be challenging, especially in FNA and core biopsies. Immunoreactivity for both HNF1β and S100α1 is present in a significantly greater proportion of oncocytomas than in chromophobe renal cell carcinomas, and these markers may aid in the differential diagnosis. Go to http://onlinelibrary.wiley.com/doi/10.1002/cncy.21530/full to read "HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies" by Conner, Hirsch, and Jo.
1
Add a comment...
 
Small HER2-positive cancers have an excellent outcome when treated with trastuzumab-based chemotherapy suggesting that less aggressive treatment approaches may be appropriate for some patients. HER2-positive cancers that co-express hormone receptors are heterogenous and a subset appear to be driven at least in part by estrogen receptor and may be optimally treated with co-inhibition of estrogen receptor and HER2 rather than chemotherapy. Go to http://onlinelibrary.wiley.com/enhanced/doi/10.1002/cncr.29060/ to read "Systemic therapy for early-stage HER2-positive breast cancers: Time for a less-is-more approach?" by Paplomata, Nahta, and O'Regan. 
1
Add a comment...
People
Have them in circles
41 people
Chris S. Paul's profile photo
Antonio Shaw's profile photo
Antonio Shaw's profile photo
Carissa Gilman's profile photo
prIME Oncology's profile photo
Hejamady S's profile photo
Maryam Yassi's profile photo
Sheng Jiang's profile photo
BioSequence's profile photo
Story
Tagline
Content from the American Cancer Society family of journals.
Introduction
From groundbreaking findings to insightful reviews, the American Cancer Society's family of journals continues to fuel new discoveries in cancer research and guide clinical practice around the world.